IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 191 filers reported holding IMMUNOVANT INC in Q3 2023. The put-call ratio across all filers is 2.28 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,611,575 | +312.8% | 328,512 | +104.0% | 0.00% | +300.0% |
| Q2 2023 | $3,055,043 | +102.2% | 161,046 | +65.3% | 0.00% | 0.0% |
| Q1 2023 | $1,511,015 | -73.3% | 97,422 | -69.5% | 0.00% | -66.7% |
| Q4 2022 | $5,663,510 | +6192.8% | 319,071 | +1881.1% | 0.00% | – |
| Q3 2022 | $90,000 | -60.2% | 16,106 | -60.9% | 0.00% | – |
| Q1 2022 | $226,000 | -79.2% | 41,178 | -67.7% | 0.00% | – |
| Q4 2021 | $1,087,000 | -82.3% | 127,554 | -81.9% | 0.00% | -100.0% |
| Q3 2021 | $6,125,000 | -34.8% | 704,856 | -20.7% | 0.00% | -33.3% |
| Q2 2021 | $9,392,000 | +4228.1% | 888,518 | +6459.3% | 0.00% | – |
| Q1 2021 | $217,000 | -58.1% | 13,546 | -7.9% | 0.00% | – |
| Q3 2020 | $518,000 | -19.1% | 14,713 | -44.1% | 0.00% | – |
| Q2 2020 | $640,000 | +244.1% | 26,321 | +119.5% | 0.00% | – |
| Q1 2020 | $186,000 | – | 11,990 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |